The Center for Cancer Immunology Research (CCIR) addresses immunology-based approaches to the treatment of cancer and has emerged as a one-of-a-kind cancer immunology research program that allows laboratory immunologists to work with clinical oncologists to develop new or improved forms of cancer immunotherapy that activate and instruct our immune system to eliminate cancer and prevent its recurrence.
Unlike targeted therapy and conventional chemotherapy for most malignancies, immunotherapy has the advantage of providing long-term clinical benefit in some patients. Although this benefit has not been seen in all patients treated with immunotherapy, one of the goals of the CCIR is to improve our understanding of the immune system, especially in the context of the tumor immune microenvironment, in order to modulate immunity to optimally enhance patient outcome.
Since the center's inception in 2003, CCIR investigators have made remarkable progress in the number of high-quality publications, level of research support, and number of investigator-initiated pre-clinical studies/clinical trials.
Center for Cancer Immunology Research (CCIR)
South Campus Research Building I
7455 Fannin Street
Houston, Texas 77054-1901